- Home
- MEOH vs MRUS Comparison
MEOH vs MRUS Comparison
Compare MEOH & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEOH
- MRUS
- Stock Information
- Founded
- MEOH 1968
- MRUS 2003
- Country
- MEOH Canada
- MRUS Netherlands
- Employees
- MEOH N/A
- MRUS N/A
- Industry
- MEOH Major Chemicals
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- MEOH Industrials
- MRUS Health Care
- Exchange
- MEOH Nasdaq
- MRUS Nasdaq
- Market Cap
- MEOH 3.1B
- MRUS 2.8B
- IPO Year
- MEOH N/A
- MRUS 2016
- Fundamental
- Price
- MEOH $44.25
- MRUS $47.37
- Analyst Decision
- MEOH Buy
- MRUS Strong Buy
- Analyst Count
- MEOH 7
- MRUS 13
- Target Price
- MEOH $62.57
- MRUS $85.67
- AVG Volume (30 Days)
- MEOH 429.6K
- MRUS 513.2K
- Earning Date
- MEOH 01-29-2025
- MRUS 02-26-2025
- Dividend Yield
- MEOH 1.62%
- MRUS N/A
- EPS Growth
- MEOH N/A
- MRUS N/A
- EPS
- MEOH 2.39
- MRUS N/A
- Revenue
- MEOH $3,719,829,000.00
- MRUS $35,932,000.00
- Revenue This Year
- MEOH $17.72
- MRUS N/A
- Revenue Next Year
- MEOH $6.30
- MRUS $42.15
- P/E Ratio
- MEOH $19.14
- MRUS N/A
- Revenue Growth
- MEOH N/A
- MRUS N/A
- 52 Week Low
- MEOH $36.13
- MRUS $37.77
- 52 Week High
- MEOH $56.43
- MRUS $61.61
- Technical
- Relative Strength Index (RSI)
- MEOH 31.00
- MRUS 71.36
- Support Level
- MEOH $50.48
- MRUS $39.67
- Resistance Level
- MEOH $54.49
- MRUS $41.15
- Average True Range (ATR)
- MEOH 1.52
- MRUS 1.71
- MACD
- MEOH -0.73
- MRUS 0.86
- Stochastic Oscillator
- MEOH 0.39
- MRUS 91.57
About MEOH Methanex Corporation
Methanex Corp manufactures and sells methanol. Methanex's customers use methanol as a feedstock to produce end-products including adhesives, foams, solvents, and windshield washer fluids. The firm also sells its products to the oil refining industry, where the methanol is blended with gasoline to produce a high-octane fuel or blended as a component of biodiesel. Methanex distributes its products through a global supply chain that includes the operation of port terminals, tankers, barges, rail cars, trucks, and pipelines. China generates the most revenue of any geographical segment.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.